231 related articles for article (PubMed ID: 32474181)
1. Novel propanolamine derivatives attached to 2-metoxifenol moiety: Synthesis, characterization, biological properties, and molecular docking studies.
Genc Bilgicli H; Ergon D; Taslimi P; Tüzün B; Akyazı Kuru İ; Zengin M; Gülçin İ
Bioorg Chem; 2020 Aug; 101():103969. PubMed ID: 32474181
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibitory effects of some acetophenone derivatives on some metabolic enzymes and molecular docking.
Taslimi P
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000210. PubMed ID: 32876951
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs.
Lolak N; Akocak S; Türkeş C; Taslimi P; Işık M; Beydemir Ş; Gülçin İ; Durgun M
Bioorg Chem; 2020 Jul; 100():103897. PubMed ID: 32413628
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
Burmaoglu S; Yilmaz AO; Polat MF; Kaya R; Gulcin İ; Algul O
Bioorg Chem; 2019 Apr; 85():191-197. PubMed ID: 30622011
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Turkan F; Cetin A; Taslimi P; Karaman M; Gulçin İ
Bioorg Chem; 2019 May; 86():420-427. PubMed ID: 30769267
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives.
Turkan F; Cetin A; Taslimi P; Karaman HS; Gulçin İ
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800359. PubMed ID: 31125504
[TBL] [Abstract][Full Text] [Related]
7. Novel eugenol derivatives: Potent acetylcholinesterase and carbonic anhydrase inhibitors.
Topal F; Gulcin I; Dastan A; Guney M
Int J Biol Macromol; 2017 Jan; 94(Pt B):845-851. PubMed ID: 27984137
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds.
Özgeriş B; Göksu S; Polat Köse L; Gülçin İ; Salmas RE; Durdagi S; Tümer F; Supuran CT
Bioorg Med Chem; 2016 May; 24(10):2318-29. PubMed ID: 27068142
[TBL] [Abstract][Full Text] [Related]
9. Novel 2-methylimidazolium salts: Synthesis, characterization, molecular docking, and carbonic anhydrase and acetylcholinesterase inhibitory properties.
Bal S; Kaya R; Gök Y; Taslimi P; Aktaş A; Karaman M; Gülçin İ
Bioorg Chem; 2020 Jan; 94():103468. PubMed ID: 31791684
[TBL] [Abstract][Full Text] [Related]
10. Pyrazole[3,4-d]pyridazine derivatives: Molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials.
Taslimi P; Türkan F; Cetin A; Burhan H; Karaman M; Bildirici I; Gulçin İ; Şen F
Bioorg Chem; 2019 Nov; 92():103213. PubMed ID: 31470200
[TBL] [Abstract][Full Text] [Related]
11. The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes.
Bayindir S; Caglayan C; Karaman M; Gülcin İ
Bioorg Chem; 2019 Sep; 90():103096. PubMed ID: 31284100
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: novel sulfamoylcarbamates and sulfamides derived from acetophenones.
Akıncıoğlu A; Akıncıoğlu H; Gülçin İ; Durdagi S; Supuran CT; Göksu S
Bioorg Med Chem; 2015 Jul; 23(13):3592-602. PubMed ID: 25921269
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors.
Bilginer S; Gul HI; Anil B; Demir Y; Gulcin I
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000243. PubMed ID: 32984993
[TBL] [Abstract][Full Text] [Related]
14. Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes.
Kucukoglu K; Gul HI; Taslimi P; Gulcin I; Supuran CT
Bioorg Chem; 2019 May; 86():316-321. PubMed ID: 30743172
[TBL] [Abstract][Full Text] [Related]
15. Phthalocyanine complexes with (4-isopropylbenzyl)oxy substituents: preparation and evaluation of anti-carbonic anhydrase, anticholinesterase enzymes and molecular docking studies.
Güzel E; Koçyiğit ÜM; Taslimi P; Gülçin İ; Erkan S; Nebioğlu M; Arslan BS; Şişman İ
J Biomol Struct Dyn; 2022 Feb; 40(2):733-741. PubMed ID: 32954954
[TBL] [Abstract][Full Text] [Related]
16. Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Istrefi Q; Türkeş C; Arslan M; Demir Y; Nixha AR; Beydemir Ş; Küfrevioğlu ÖI
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900383. PubMed ID: 32285537
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates.
Göçer H; Akincioğlu A; Göksu S; Gülçin İ; Supuran CT
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):316-20. PubMed ID: 24964347
[TBL] [Abstract][Full Text] [Related]
18. The synthesis of novel sulfamides derived from β-benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors.
Akıncıoğlu A; Kocaman E; Akıncıoğlu H; Salmas RE; Durdagi S; Gülçin İ; Supuran CT; Göksu S
Bioorg Chem; 2017 Oct; 74():238-250. PubMed ID: 28866249
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, crystal structure of novel bis-thiomethylcyclohexanone derivatives and their inhibitory properties against some metabolic enzymes.
Biçer A; Taslimi P; Yakalı G; Gülçin I; Serdar Gültekin M; Turgut Cin G
Bioorg Chem; 2019 Feb; 82():393-404. PubMed ID: 30428418
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and SAR of arylated indenoquinoline-based cholinesterase and carbonic anhydrase inhibitors.
Ekiz M; Tutar A; Ökten S; Bütün B; Koçyiğit ÜM; Taslimi P; Topçu G
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800167. PubMed ID: 30079554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
